GV.PA
Genomic Vision SA
Price:  
0.00 
EUR
Volume:  
38,489,200.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GV.PA WACC - Weighted Average Cost of Capital

The WACC of Genomic Vision SA (GV.PA) is 4.7%.

The Cost of Equity of Genomic Vision SA (GV.PA) is 8.25%.
The Cost of Debt of Genomic Vision SA (GV.PA) is 5.00%.

Range Selected
Cost of equity 5.80% - 10.70% 8.25%
Tax rate 25.90% - 27.10% 26.50%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.2% - 5.2% 4.7%
WACC

GV.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.48 0.99
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.80% 10.70%
Tax rate 25.90% 27.10%
Debt/Equity ratio 3.51 3.51
Cost of debt 5.00% 5.00%
After-tax WACC 4.2% 5.2%
Selected WACC 4.7%